531043 Stock Overview
Dhanvantri Jeevan Rekha Limited provides medical and healthcare services in India.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Dhanvantri Jeevan Rekha Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹21.23 |
| 52 Week High | ₹27.73 |
| 52 Week Low | ₹10.31 |
| Beta | 0.34 |
| 1 Month Change | -13.59% |
| 3 Month Change | 6.68% |
| 1 Year Change | 39.21% |
| 3 Year Change | 228.64% |
| 5 Year Change | 57.26% |
| Change since IPO | 169.76% |
Recent News & Updates
Recent updates
Shareholder Returns
| 531043 | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 2.1% | 1.3% | 2.8% |
| 1Y | 39.2% | 64.0% | 46.6% |
Return vs Industry: 531043 underperformed the Indian Healthcare industry which returned 65.6% over the past year.
Return vs Market: 531043 underperformed the Indian Market which returned 46.4% over the past year.
Price Volatility
| 531043 volatility | |
|---|---|
| 531043 Average Weekly Movement | 7.0% |
| Healthcare Industry Average Movement | 6.4% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 531043's share price has been volatile over the past 3 months.
Volatility Over Time: 531043's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 95 | Shalini Sharma | www.djrl.org.in |
Dhanvantri Jeevan Rekha Limited provides medical and healthcare services in India. The company offers diagnostic and therapeutic services. It also provides specialty services, such as cardiology, gastroenterology, neurology, urology, and other diagnostic services.
Dhanvantri Jeevan Rekha Limited Fundamentals Summary
| 531043 fundamental statistics | |
|---|---|
| Market cap | ₹87.01m |
| Earnings (TTM) | ₹2.43m |
| Revenue (TTM) | ₹199.85m |
35.8x
P/E Ratio0.4x
P/S RatioIs 531043 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 531043 income statement (TTM) | |
|---|---|
| Revenue | ₹199.85m |
| Cost of Revenue | ₹90.69m |
| Gross Profit | ₹109.16m |
| Other Expenses | ₹106.73m |
| Earnings | ₹2.43m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.59 |
| Gross Margin | 54.62% |
| Net Profit Margin | 1.22% |
| Debt/Equity Ratio | 0% |
How did 531043 perform over the long term?
See historical performance and comparison